Aug 27 (Reuters) - Abbott Laboratories (ABT.N), opens new tab has restarted production of its Similac infant formula at the plant in Sturgis, Michigan at the center of the U.S. baby formula shortage.

Similac maker Abbott is under federal criminal investigation for its role in the baby formula shortage. The possible charges carry penalties of up to $500,000 for corporations and up to a year of ...

More food for your baby sold under the Similac and Pedialyte brands is being recalled by Abbott Nutrition, whose salmonella and cronobacter troubles earlier in the year were linked to infant ...

Abbott announced the recall of some ready-to-feed liquid products for infants and children, including the brands Similac and Pedialyte Electrolyte Solution, due to spoilage concerns as the bottle ...

Anyone keeping score at home will probably know that Abbott’s new Similac baby formula recall isn’t the company’s first recall this year. We saw a massive recall action in mid-February ...

The company said several Similac products including Pro-Total Comfort, 360 Total Care, 360 Total Care Sensitive, Special Care 24, Stage 1, Water (Sterilized), and NeoSure. Pedialyte Electrolyte ...

Abbott Nutrition announce this week that it is restarting production of Similac baby formula at its troubled plant in Sturgis, Michigan, which was shut down earlier this year and contributed to a ...

Abbott Nutrition i s restarting production of its most popular baby formula, Similac, at its Michigan plant, with the product expected to hit shelves in about six weeks. The formula will undergo ...

But MDHHS announced on Wednesday that at the onset of March, WIC benefits will, once again, only be usable on Similac formula. The agency noted “Abbott’s recent production levels and its ...